Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
XR Immersive Tech Inc. ( (TSE:VRAI) ) has issued an announcement.
XR Immersive Tech Inc. announced the termination of its proposed acquisition of InsulinQ’s Continuous Glucose Monitoring technology due to unmet closing conditions, with no financial obligations arising from the termination. Additionally, the company clarified the terms of its licensing agreement with Deploy Reality, which grants operational control over the SVR platform while retaining ownership, highlighting the related party nature of the transaction.
More about XR Immersive Tech Inc.
XR Immersive Tech Inc. operates in the immersive technology industry, focusing on developing and providing virtual and augmented reality solutions. The company is involved in licensing agreements and partnerships to expand its market presence and leverage its technological capabilities.
Average Trading Volume: 5,768
Technical Sentiment Signal: Buy
Current Market Cap: C$6.23M
See more insights into VRAI stock on TipRanks’ Stock Analysis page.